{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T04:24:37Z","timestamp":1784953477761,"version":"3.55.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,16]]},"DOI":"10.7759\/cureus.17219","type":"journal-article","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T13:29:06Z","timestamp":1629120546000},"source":"Crossref","is-referenced-by-count":21,"title":["A Comprehensive Review of Intranasal Insulin and Its Effect on the Cognitive Function of Diabetics"],"prefix":"10.7759","author":[{"given":"Mrunanjali","family":"Gaddam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaithanya","family":"Avanthika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharan","family":"Jhaveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivonne","family":"De la Hoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujana","family":"Sanka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri Rupa","family":"Goli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Insulin and insulin resistance","volume":"26","author":"Wilcox G","year":"2005","unstructured":"Wilcox G. Insulin and insulin resistance. Clin Biochem Rev. 2005, 26:19-39.","journal-title":"Clin Biochem Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0169-409x(98)00073-8","article-title":"Intranasal insulin delivery and therapy","volume":"35","author":"Hinchcliffe M","year":"1999","unstructured":"Hinchcliffe M, Illum L. Intranasal insulin delivery and therapy. Adv Drug Deliv Rev. 1999, 35:199-234. 10.1016\/s0169-409x(98)00073-8","journal-title":"Adv Drug Deliv Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01907-w","article-title":"Intranasal insulin enhances brain functional connectivity mediating the relationship between adiposity and subjective feeling of hunger","volume":"7","author":"Kullmann S","year":"2017","unstructured":"Kullmann S, Heni M, Veit R, et al.. Intranasal insulin enhances brain functional connectivity mediating the relationship between adiposity and subjective feeling of hunger. Sci Rep. 2017, 7:1627. 10.1038\/s41598-017-01907-w","journal-title":"Sci Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1802","article-title":"Effect of intranasal insulin on cognitive function: a systematic review","volume":"97","author":"Shemesh E","year":"2012","unstructured":"Shemesh E, Rudich A, Harman-Boehm I, Cukierman-Yaffe T. Effect of intranasal insulin on cognitive function: a systematic review. J Clin Endocrinol Metab. 2012, 97:366-76. 10.1210\/jc.2011-1802","journal-title":"J Clin Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/jne.12934","article-title":"Intranasal insulin","volume":"33","author":"Hallschmid M","year":"2021","unstructured":"Hallschmid M. Intranasal insulin. J Neuroendocrinol. 2021, 33:e12934. 10.1111\/jne.12934","journal-title":"J Neuroendocrinol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2337\/db14-1000","article-title":"Intranasal insulin enhanced resting-state functional connectivity of hippocampal regions in type 2 diabetes","volume":"64","author":"Zhang H","year":"2015","unstructured":"Zhang H, Hao Y, Manor B, et al.. Intranasal insulin enhanced resting-state functional connectivity of hippocampal regions in type 2 diabetes. Diabetes. 2015, 64:1025-34. 10.2337\/db14-1000","journal-title":"Diabetes"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-005-0023-4","article-title":"Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies","volume":"48","author":"Cukierman T","year":"2005","unstructured":"Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies. Diabetologia. 2005, 48:2460-9. 10.1007\/s00125-005-0023-4","journal-title":"Diabetologia"},{"key":"ref8","unstructured":"Global report on diabetes. World Health Organization. (2016). Accessed. July 25, 2021: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/diabetes."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2020.105934","article-title":"Memory advancement by intranasal insulin in type 2 diabetes (MemAID) randomized controlled clinical trial: Design, methods and rationale","volume":"89","author":"Galindo-Mendez B","year":"2020","unstructured":"Galindo-Mendez B, Trevino JA, McGlinchey R, et al.. Memory advancement by intranasal insulin in type 2 diabetes (MemAID) randomized controlled clinical trial: Design, methods and rationale. Contemp Clin Trials. 2020, 89:105934. 10.1016\/j.cct.2020.105934","journal-title":"Contemp Clin Trials"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-016-0775-x","article-title":"Diabetes and cognitive impairment","volume":"16","author":"Zilliox LA","year":"2016","unstructured":"Zilliox LA, Chadrasekaran K, Kwan JY, Russell JW. Diabetes and cognitive impairment. Curr Diab Rep. 2016, 16:87. 10.1007\/s11892-016-0775-x","journal-title":"Curr Diab Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2004.04.003","article-title":"Intranasal insulin improves memory in humans","volume":"29","author":"Benedict C","year":"2004","unstructured":"Benedict C, Hallschmid M, Hatke A, Schultes B, Fehm HL, Born J, Kern W. Intranasal insulin improves memory in humans. Psychoneuroendocrinology. 2004, 29:1326-34. 10.1016\/j.psyneuen.2004.04.003","journal-title":"Psychoneuroendocrinology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2009.08.003","article-title":"Intranasal insulin: from nose to brain","volume":"26","author":"Henkin RI","year":"2010","unstructured":"Henkin RI. Intranasal insulin: from nose to brain. Nutrition. 2010, 26:624-33. 10.1016\/j.nut.2009.08.003","journal-title":"Nutrition"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2009.08.001","article-title":"Inhaled insulin-intrapulmonary, intranasal, and other routes of administration: mechanisms of action","volume":"26","author":"Henkin RI","year":"2010","unstructured":"Henkin RI. Inhaled insulin-intrapulmonary, intranasal, and other routes of administration: mechanisms of action. Nutrition. 2010, 26:33-9. 10.1016\/j.nut.2009.08.001","journal-title":"Nutrition"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.2012.01555.x","article-title":"Intranasal delivery of insulin via the olfactory nerve pathway","volume":"64","author":"Renner DB","year":"2012","unstructured":"Renner DB, Svitak AL, Gallus NJ, Ericson ME, Frey WH, Hanson LR. Intranasal delivery of insulin via the olfactory nerve pathway. J Pharm Pharmacol. 2012, 64:1709-14. 10.1111\/j.2042-7158.2012.01555.x","journal-title":"J Pharm Pharmacol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-015-2386-8","article-title":"Cerebral insulin, insulin signaling pathway, and brain angiogenesis","volume":"37","author":"Zeng Y","year":"2016","unstructured":"Zeng Y, Zhang L, Hu Z. Cerebral insulin, insulin signaling pathway, and brain angiogenesis. Neurol Sci. 2016, 37:9-16. 10.1007\/s10072-015-2386-8","journal-title":"Neurol Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2011.01490.x","article-title":"Intranasal administration of insulin to the brain impacts cognitive function and peripheral metabolism","volume":"14","author":"Ott V","year":"2012","unstructured":"Ott V, Benedict C, Schultes B, Born J, Hallschmid M. Intranasal administration of insulin to the brain impacts cognitive function and peripheral metabolism. Diabetes Obes Metab. 2012, 14:214-21. 10.1111\/j.1463-1326.2011.01490.x","journal-title":"Diabetes Obes Metab"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201802043R","article-title":"Insulin deficiency and intranasal insulin alter brain mitochondrial function: a potential factor for dementia in diabetes","volume":"33","author":"Ruegsegger GN","year":"2019","unstructured":"Ruegsegger GN, Manjunatha S, Summer P, et al.. Insulin deficiency and intranasal insulin alter brain mitochondrial function: a potential factor for dementia in diabetes. FASEB J. 2019, 33:4458-72. 10.1096\/fj.201802043R","journal-title":"FASEB J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2005.7.124","article-title":"Pharmacokinetics and pharmacodynamics of intranasal insulin administered to healthy subjects in escalating doses","volume":"7","author":"Leary AC","year":"2005","unstructured":"Leary AC, Stote RM, Breedt HJ, O'Brien J, Buckley B. Pharmacokinetics and pharmacodynamics of intranasal insulin administered to healthy subjects in escalating doses. Diabetes Technol Ther. 2005, 7:124-30. 10.1089\/dia.2005.7.124","journal-title":"Diabetes Technol Ther"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2006.8.81","article-title":"Pharmacokinetics and pharmacodynamics of intranasal insulin administered to patients with type 1 diabetes: a preliminary study","volume":"8","author":"Leary AC","year":"2006","unstructured":"Leary AC, Stote RM, Cussen K, O'Brien J, Leary WP, Buckley B. Pharmacokinetics and pharmacodynamics of intranasal insulin administered to patients with type 1 diabetes: a preliminary study. Diabetes Technol Ther. 2006, 8:81-8. 10.1089\/dia.2006.8.81","journal-title":"Diabetes Technol Ther"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/193229680800200613","article-title":"Pharmacokinetics and pharmacodynamics of intranasal insulin spray (Nasulin) administered to healthy male volunteers: influence of the nasal cycle","volume":"2","author":"Leary AC","year":"2008","unstructured":"Leary AC, Dowling M, Cussen K, O'Brien J, Stote RM. Pharmacokinetics and pharmacodynamics of intranasal insulin spray (Nasulin) administered to healthy male volunteers: influence of the nasal cycle. J Diabetes Sci Technol. 2008, 2:1054-60. 10.1177\/193229680800200613","journal-title":"J Diabetes Sci Technol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.1992.tb01792.x","article-title":"Intranasal administration of insulin with phospholipid as absorption enhancer: pharmacokinetics in normal subjects","volume":"9","author":"Drejer K","year":"1992","unstructured":"Drejer K, Vaag A, Bech K, Hansen P, S\u00f8rensen AR, Mygind N. Intranasal administration of insulin with phospholipid as absorption enhancer: pharmacokinetics in normal subjects. Diabet Med. 1992, 9:335-40. 10.1111\/j.1464-5491.1992.tb01792.x","journal-title":"Diabet Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1177\/193229681000400314","article-title":"Comparison pharmacokinetics of two concentrations (0.7% and 1.0%) of Nasulin, an ultra-rapid-acting intranasal insulin formulation","volume":"4","author":"Stote R","year":"2010","unstructured":"Stote R, Marbury T, Shi L, Miller M, Strange P. Comparison pharmacokinetics of two concentrations (0.7% and 1.0%) of Nasulin, an ultra-rapid-acting intranasal insulin formulation. J Diabetes Sci Technol. 2010, 4:603-9. 10.1177\/193229681000400314","journal-title":"J Diabetes Sci Technol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8227(91)90083-p","article-title":"Intranasal administration of insulin to humans","volume":"12","author":"Gizurarson S","year":"1991","unstructured":"Gizurarson S, Bechgaard E. Intranasal administration of insulin to humans. Diabetes Res Clin Pract. 1991, 12:71-84. 10.1016\/0168-8227(91)90083-p","journal-title":"Diabetes Res Clin Pract"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199142020-00004","article-title":"Recent developments in insulin delivery techniques. current status and future potential","volume":"42","author":"Kennedy FP","year":"1991","unstructured":"Kennedy FP. Recent developments in insulin delivery techniques. current status and future potential. Drugs. 1991, 42:213-27. 10.2165\/00003495-199142020-00004","journal-title":"Drugs"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8227(91)90035-c","article-title":"Could intranasal insulin be useful in the treatment of non-insulin-dependent diabetes mellitus?","volume":"13","author":"Kimmerle R","year":"1991","unstructured":"Kimmerle R, Griffing G, McCall A, Ruderman NB, Stoltz E, Melby JC. Could intranasal insulin be useful in the treatment of non-insulin-dependent diabetes mellitus?. Diabetes Res Clin Pract. 1991, 13:69-75. 10.1016\/0168-8227(91)90035-c","journal-title":"Diabetes Res Clin Pract"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.21.7419","article-title":"Nasal absorption of insulin: enhancement by hydrophobic bile salts","volume":"82","author":"Gordon GS","year":"1985","unstructured":"Gordon GS, Moses AC, Silver RD, Flier JS, Carey MC. Nasal absorption of insulin: enhancement by hydrophobic bile salts. Proc Natl Acad Sci USA. 1985, 82:7419-23. 10.1073\/pnas.82.21.7419","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8227(87)80039-6","article-title":"Effects of intranasal insulin in non-obese type II diabetics","volume":"4","author":"Frauman A","year":"1987","unstructured":"Frauman A, Jerums G, Louis W. Effects of intranasal insulin in non-obese type II diabetics. Diabetes Res Clin Pract. 1987, 4:197-202. 10.1016\/S0168-8227(87)80039-6","journal-title":"Diabetes Res Clin Pract"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/BF00401839","article-title":"Intranasal insulin therapy: the clinical realities","volume":"38","author":"Hilsted J","year":"1995","unstructured":"Hilsted J, Madsbad S, Hvidberg A, et al.. Intranasal insulin therapy: the clinical realities. Diabetologia. 1995, 38:680-684. 10.1007\/BF00401839","journal-title":"Diabetologia"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-5491.2001.00528.x","article-title":"Efficacy and tolerance of intranasal insulin administered during 4 months in severely hyperglycaemic Type 2 diabetic patients with oral drug failure: a cross-over study","volume":"18","author":"Lalej-Bennis D","year":"2001","unstructured":"Lalej-Bennis D, Boillot J, Bardin C, et al.. Efficacy and tolerance of intranasal insulin administered during 4 months in severely hyperglycaemic Type 2 diabetic patients with oral drug failure: a cross-over study. Diabet Med. 2001, 18:614-8. 10.1046\/j.1464-5491.2001.00528.x","journal-title":"Diabet Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198504253121702","article-title":"Intranasal aerosolized insulin. mixed-meal studies and long-term use in type I diabetes","volume":"312","author":"Salzman R","year":"1985","unstructured":"Salzman R, Manson JE, Griffing GT, et al.. Intranasal aerosolized insulin. mixed-meal studies and long-term use in type I diabetes. N Engl J Med. 1985, 312:1078-84. 10.1056\/NEJM198504253121702","journal-title":"N Engl J Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.10.2348","article-title":"Pancreatic beta-cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for type 1 diabetes","volume":"27","author":"Harrison LC","year":"2004","unstructured":"Harrison LC, Honeyman MC, Steele CE, et al.. Pancreatic beta-cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for type 1 diabetes. Diabetes Care. 2004, 27:2348-55. 10.2337\/diacare.27.10.2348","journal-title":"Diabetes Care"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2010.08.026","article-title":"Intranasal insulin as a therapeutic option in the treatment of cognitive impairments","volume":"46","author":"Benedict C","year":"2011","unstructured":"Benedict C, Frey WH 2nd, Schi\u00f6th HB, Schultes B, Born J, Hallschmid M. Intranasal insulin as a therapeutic option in the treatment of cognitive impairments. Exp Gerontol. 2011, 46:112-5. 10.1016\/j.exger.2010.08.026","journal-title":"Exp Gerontol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-141791","article-title":"Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia","volume":"44","author":"Claxton A","year":"2015","unstructured":"Claxton A, Baker LD, Hanson A, et al.. Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia. J Alzheimers Dis. 2015, 44:897-906. 10.3233\/JAD-141791","journal-title":"J Alzheimers Dis"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glu314","article-title":"Intranasal insulin improves age-related cognitive deficits and reverses electrophysiological correlates of brain aging","volume":"71","author":"Maimaiti S","year":"2016","unstructured":"Maimaiti S, Anderson KL, DeMoll C, et al.. Intranasal insulin improves age-related cognitive deficits and reverses electrophysiological correlates of brain aging. J Gerontol A Biol Sci Med Sci. 2016, 71:30-9. 10.1093\/gerona\/glu314","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-017-0198-4","article-title":"Intranasal insulin reverts central pathology and cognitive impairment in diabetic mother offspring","volume":"12","author":"Ramos-Rodriguez JJ","year":"2017","unstructured":"Ramos-Rodriguez JJ, Sanchez-Sotano D, Doblas-Marquez A, Infante-Garcia C, Lubian-Lopez S, Garcia-Alloza M. Intranasal insulin reverts central pathology and cognitive impairment in diabetic mother offspring. Mol Neurodegener. 2017, 12:57. 10.1186\/s13024-017-0198-4","journal-title":"Mol Neurodegener"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-018-8768-0","article-title":"Intranasal insulin in Alzheimer's dementia or mild cognitive impairment: a systematic review","volume":"265","author":"Avgerinos KI","year":"2018","unstructured":"Avgerinos KI, Kalaitzidis G, Malli A, Kalaitzoglou D, Myserlis PG, Lioutas VA. Intranasal insulin in Alzheimer's dementia or mild cognitive impairment: a systematic review. J Neurol. 2018, 265:1497-510. 10.1007\/s00415-018-8768-0","journal-title":"J Neurol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00663","article-title":"Metabolic and cognitive outcomes of subchronic once-daily intranasal insulin administration in healthy men","volume":"9","author":"Ritze Y","year":"2018","unstructured":"Ritze Y, Kern W, Ebner EM, Jahn S, Benedict C, Hallschmid M. Metabolic and cognitive outcomes of subchronic once-daily intranasal insulin administration in healthy men. Front Endocrinol (Lausanne). 2018, 9:663. 10.3389\/fendo.2018.00663","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-180578","article-title":"Extracellular vesicle biomarkers track cognitive changes following intranasal insulin in Alzheimer's disease","volume":"69","author":"Mustapic M","year":"2019","unstructured":"Mustapic M, Tran J, Craft S, Kapogiannis D. Extracellular vesicle biomarkers track cognitive changes following intranasal insulin in Alzheimer's disease. J Alzheimers Dis. 2019, 69:489-98. 10.3233\/JAD-180578","journal-title":"J Alzheimers Dis"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0214364","article-title":"Safety and preliminary efficacy of intranasal insulin for cognitive impairment in Parkinson disease and multiple system atrophy: a double-blinded placebo-controlled pilot study","volume":"14","author":"Novak P","year":"2019","unstructured":"Novak P, Pimentel Maldonado DA, Novak V. Safety and preliminary efficacy of intranasal insulin for cognitive impairment in Parkinson disease and multiple system atrophy: a double-blinded placebo-controlled pilot study. PLoS One. 2019, 14:e0214364. 10.1371\/journal.pone.0214364","journal-title":"PLoS One"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.1840","article-title":"Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and Alzheimer disease dementia: a randomized clinical trial","volume":"77","author":"Craft S","year":"2020","unstructured":"Craft S, Raman R, Chow TW, et al.. Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and Alzheimer disease dementia: a randomized clinical trial. JAMA Neurol. 2020, 77:1099-109. 10.1001\/jamaneurol.2020.1840","journal-title":"JAMA Neurol"},{"key":"ref41","article-title":"Alternative delivery systems for peptides and proteins as drugs","volume":"5","author":"Eppstein DA","year":"1988","unstructured":"Eppstein DA, Longenecker JP. Alternative delivery systems for peptides and proteins as drugs. Crit Rev Ther Drug Carrier Syst. 1988, 5:99-139.","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/0169-409X(89)90018-5","article-title":"Penetration and enzymatic barriers to peptide and protein absorption","volume":"4","author":"Lee VHL","year":"1990","unstructured":"Lee VHL, Yamamoto A. Penetration and enzymatic barriers to peptide and protein absorption. Adv Drug Deliv Rev. 1990, 4:171-207. 10.1016\/0169-409X(89)90018-5","journal-title":"Adv Drug Deliv Rev"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/0169-409x(92)90005-b","article-title":"(D) Routes of delivery: case studies: (5) oral absorption of peptides and proteins","volume":"8","author":"Smith PL","year":"1992","unstructured":"Smith PL, Wall DA, Gochoco C.H, Wilson G. (D) Routes of delivery: case studies: (5) oral absorption of peptides and proteins. Adv Drug Deliv. Rev. 1992, 8:253-290. 10.1016\/0169-409x(92)90005-b","journal-title":"Adv Drug Deliv. Rev"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.4155\/tde.13.104","article-title":"Basics and recent advances in peptide and protein drug delivery","volume":"4","author":"Bruno BJ","year":"2013","unstructured":"Bruno BJ, Miller GD, Lim CS. Basics and recent advances in peptide and protein drug delivery. Ther Deliv. 2013, 4:1443-67. 10.4155\/tde.13.104","journal-title":"Ther Deliv"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1111\/jphp.12607","article-title":"Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities","volume":"68","author":"Wong CY","year":"2016","unstructured":"Wong CY, Martinez J, Dass CR. Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities. J Pharm Pharmacol. 2016, 68:1093-108. 10.1111\/jphp.12607","journal-title":"J Pharm Pharmacol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198917050-00001","article-title":"Intranasal drug delivery. potential advantages and limitations from a clinical pharmacokinetic perspective","volume":"17","author":"Pontiroli AE","year":"1989","unstructured":"Pontiroli AE, Calderara A, Pozza G. Intranasal drug delivery. potential advantages and limitations from a clinical pharmacokinetic perspective. Clin Pharmacokinet. 1989, 17:299-307. 10.2165\/00003088-198917050-00001","journal-title":"Clin Pharmacokinet"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.13.9.923","article-title":"Monomeric insulins and their experimental and clinical implications","volume":"13","author":"Brange J","year":"1990","unstructured":"Brange J, Owens DR, Kang S, V\u00f8lund A. Monomeric insulins and their experimental and clinical implications. Diabetes Care. 1990, 13:923-54. 10.2337\/diacare.13.9.923","journal-title":"Diabetes Care"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-92-1-59","article-title":"Alterations in insulin absorption and in blood glucose control associated with varying insulin injection sites in diabetic patients","volume":"92","author":"Koivisto VA","year":"1980","unstructured":"Koivisto VA, Felig P. Alterations in insulin absorption and in blood glucose control associated with varying insulin injection sites in diabetic patients. Ann Intern Med. 1980, 92:59-61. 10.7326\/0003-4819-92-1-59","journal-title":"Ann Intern Med"},{"key":"ref49","article-title":"Nonparenteral administration of peptide and protein drugs","volume":"3","author":"Siddiqui O","year":"1987","unstructured":"Siddiqui O, Chien YW. Nonparenteral administration of peptide and protein drugs. Crit Rev Ther Drug Carrier Syst. 1987, 3:195-208.","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5173(88)90246-3","article-title":"Systemic delivery of therapeutic peptides and proteins","volume":"48","author":"Banga AK","year":"1988","unstructured":"Banga AK, Chien YW. Systemic delivery of therapeutic peptides and proteins. Int J Pharm. 1988, 48:15-50. 10.1016\/0378-5173(88)90246-3","journal-title":"Int J Pharm"},{"key":"ref51","doi-asserted-by":"crossref","DOI":"10.4103\/0973-8398.139177","article-title":"Novel noninvasive techniques in management of diabetes","volume":"8","author":"Sameer N","year":"2014","unstructured":"Sameer N. Novel noninvasive techniques in management of diabetes. Asian J Pharm. 2014, 8:141-10.","journal-title":"Asian J Pharm"},{"key":"ref52","article-title":"Intranasal drug delivery for systemic medications","volume":"4","author":"Chien YW","year":"1987","unstructured":"Chien YW, Chang SF. Intranasal drug delivery for systemic medications. Crit Rev Ther Drug Carrier Syst. 1987, 4:67-194.","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2010.03.011","article-title":"New strategies to improve the intranasal absorption of insulin","volume":"15","author":"Duan X","year":"2010","unstructured":"Duan X, Mao S. New strategies to improve the intranasal absorption of insulin. Drug Discov Today. 2010, 15:416-27. 10.1016\/j.drudis.2010.03.011","journal-title":"Drug Discov Today"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1021\/mp400680d","article-title":"Strategies to deliver peptide drugs to the brain","volume":"11","author":"Lalatsa A","year":"2014","unstructured":"Lalatsa A, Schatzlein AG, Uchegbu IF. Strategies to deliver peptide drugs to the brain. Mol Pharm. 2014, 11:1081-93. 10.1021\/mp400680d","journal-title":"Mol Pharm"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/bs.apha.2014.06.004","article-title":"Delivery of therapeutic peptides and proteins to the CNS","volume":"71","author":"Salameh TS","year":"2014","unstructured":"Salameh TS, Banks WA. Delivery of therapeutic peptides and proteins to the CNS. Adv Pharmacol. 2014, 71:277-99. 10.1016\/bs.apha.2014.06.004","journal-title":"Adv Pharmacol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.7b00434","article-title":"Pharmacokinetics of intranasal versus subcutaneous insulin in the mouse","volume":"9","author":"Nedelcovych MT","year":"2018","unstructured":"Nedelcovych MT, Gadiano AJ, Wu Y, et al.. Pharmacokinetics of intranasal versus subcutaneous insulin in the mouse. ACS Chem Neurosci. 2018, 9:809-16. 10.1021\/acschemneuro.7b00434","journal-title":"ACS Chem Neurosci"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-150307","article-title":"Central nervous system delivery of intranasal insulin: mechanisms of uptake and effects on cognition","volume":"47","author":"Salameh TS","year":"2015","unstructured":"Salameh TS, Bullock KM, Hujoel IA, et al.. Central nervous system delivery of intranasal insulin: mechanisms of uptake and effects on cognition. J Alzheimers Dis. 2015, 47:715-28. 10.3233\/JAD-150307","journal-title":"J Alzheimers Dis"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.397","article-title":"Intranasally administered insulin intended for prevention of type 1 diabetes--a safety study in healthy adults","volume":"19","author":"Kupila A","year":"2003","unstructured":"Kupila A, Sipil\u00e4 J, Keskinen P, Simell T, Knip M, Pulkki K, Simell O. Intranasally administered insulin intended for prevention of type 1 diabetes--a safety study in healthy adults. Diabetes Metab Res Rev. 2003, 19:415-20. 10.1002\/dmrr.397","journal-title":"Diabetes Metab Res Rev"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2005.03.016","article-title":"Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype","volume":"27","author":"Reger MA","year":"2006","unstructured":"Reger MA, Watson GS, Frey WH 2nd, et al.. Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype. Neurobiol Aging. 2006, 27:451-8. 10.1016\/j.neurobiolaging.2005.03.016","journal-title":"Neurobiol Aging"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200342130-00003","article-title":"Absorption enhancers for nasal drug delivery","volume":"42","author":"Davis SS","year":"2003","unstructured":"Davis SS, Illum L. Absorption enhancers for nasal drug delivery. Clin Pharmacokinet. 2003, 42:1107-28. 10.2165\/00003088-200342130-00003","journal-title":"Clin Pharmacokinet"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600760709","article-title":"Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity","volume":"76","author":"McMartin C","year":"1987","unstructured":"McMartin C, Hutchinson LE, Hyde R, Peters GE. Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity. J Pharm Sci. 1987, 76:535-40. 10.1002\/jps.2600760709","journal-title":"J Pharm Sci"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.4103\/2231-4040.90876","article-title":"A review on mucoadhesive polymer used in nasal drug delivery system","volume":"2","author":"Chaturvedi M","year":"2011","unstructured":"Chaturvedi M, Kumar M, Pathak K. A review on mucoadhesive polymer used in nasal drug delivery system. J Adv Pharm Technol Res. 2011, 2:215-22. 10.4103\/2231-4040.90876","journal-title":"J Adv Pharm Technol Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/67756-a-comprehensive-review-of-intranasal-insulin-and-its-effect-on-the-cognitive-function-of-diabetics","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:15Z","timestamp":1707507255000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/67756-a-comprehensive-review-of-intranasal-insulin-and-its-effect-on-the-cognitive-function-of-diabetics"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,16]]},"references-count":62,"URL":"https:\/\/doi.org\/10.7759\/cureus.17219","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,16]]}}}